Nano-X Imaging Ltd
NASDAQ:NNOX
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| IL |
|
Nano-X Imaging Ltd
NASDAQ:NNOX
|
164.1m USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
186.1B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
170.4B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
130B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.5B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.6B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.8B EUR |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.9B USD |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.2B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.6B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
33.1B USD |
Loading...
|
Market Distribution
| Min | -11 239.1% |
| 30th Percentile | 17.6% |
| Median | 29.8% |
| 70th Percentile | 50.4% |
| Max | 208.2% |
Other Profitability Ratios
Nano-X Imaging Ltd
Glance View
Nano-X Imaging Ltd. engages in the development of medical imaging systems.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Nano-X Imaging Ltd is -98%, which is below its 3-year median of -82.5%.
Over the last 3 years, Nano-X Imaging Ltd’s Gross Margin has decreased from -85.8% to -98%. During this period, it reached a low of -100.9% on Jun 30, 2025 and a high of -66.6% on Dec 31, 2023.
